Deep Dives, AI, Drug Development, Drug Discovery.
metastatic relapse over the next five years. The results, showing accuracy of about 81%, were presented at the annual meeting of the European Society of Medical Oncology. Before that, Owkin demonstrated it could help predict treatment responses in mesothelioma, a deadly, aggressive form of cancer,